Cluvot

Cluvot is a pharmaceutical product containing Human Coagulation Factor XIII, used for managing bleeding disorders. This intravenous medication supports blood clotting and is manufactured by CSL Behring E.P.E.

Cluvot is primarily used to treat bleeding disorders caused by a deficiency in Human Coagulation Factor XIII. This medication helps in the clotting process, which is essential for controlling bleeding. It is often prescribed for individuals who experience frequent or prolonged bleeding episodes due to this specific factor deficiency.

Common effects of Cluvot may include reactions at the injection site, such as redness or swelling. Some individuals might experience allergic reactions, which can manifest as rash, itching, or difficulty breathing. It is important to monitor for any unusual symptoms and consult a healthcare provider if they occur.

Cluvot should be handled with care to ensure sterility and proper administration. It is crucial to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Individuals with known allergies to any components of the medication should avoid its use.

Cluvot may interact with other medications that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements might also influence the effectiveness of Cluvot.